Related Experiment Videos
Oral myiasis treated with ivermectin: case report.
Elio Hitoshi Shinohara1, Marcelo Zillo Martini, Humberto Gomes de Oliveira Neto
1Department of Oral and Maxillofacial Surgery, Conjunto Hospitalar do Mandaqui, SUS-SP, São Paulo, SP, Brazil.
Brazilian Dental Journal
|August 24, 2004
Summary
Oral myiasis, a dangerous condition, can now be treated with ivermectin. This medication offers a less invasive alternative to painful manual removal of maggots, improving patient outcomes.
Area of Science:
- Dentistry
- Parasitology
- Pharmacology
Background:
- Oral myiasis is a rare but life-threatening condition.
- Conventional treatment involves painful, distressing mechanical larval removal.
- Patients with disabilities may face unique challenges in treatment.
Observation:
- A case of oral myiasis in a patient with cerebral palsy was reported.
- The patient underwent successful treatment with ivermectin.
- This highlights a potential alternative to traditional methods.
Findings:
- Ivermectin demonstrated efficacy in treating oral myiasis.
- The drug offers a less invasive and distressing treatment option.
- Successful application in a patient with cerebral palsy is documented.
Implications:
- Ivermectin presents a viable, less invasive therapeutic option for oral myiasis.
- This approach may improve patient comfort and reduce treatment burden.
- Further research into ivermectin's role in managing oral myiasis is warranted.